Prion diseases

Current Opinion in Neurology

Volumn 10, Issue 3, 1997, Pages 273-281

  Korczyn, Amos D ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; ELECTROENCEPHALOGRAM; EVOKED RESPONSE; GENE MUTATION; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; HEREDITY; HUMAN; INSOMNIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PRION DISEASE; REVIEW; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPECIES DIFFERENCE;

ANIMALS; HUMANS; PRION DISEASES;

EID: 0030804782     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-199706000-00018     Document Type: Review

References (86)

1. Prusiner SB: Human prion diseases and neurodegeneratlon. Curr Topics Microbiol Immunol 1996, 207:1-17. This is an extensive review describing in detail the 'prion only' hypothesis, and the presumed molecular mechanisms of prion diseases.
2. Manuelidis L, Sklaviadis, Akowitz A, Fritch W: Viral particles are required for infection in neurodegenerative Creutzfeldt-Jakob disease. Proc Acad Nat Sci U S A 1995, 92:5124-5128.
3. Manuelidis L, Fritch W: Infectivity and host responses in Creutzfeldt-Jakob disease. Virology 1996, 216:46-59.
4. Lasmézas C, Deslys J-P, Robain O, Jaegly A, Beringue V, Peyrin J-M, Fournier J-G, Hauw J-J, Rossier J, Dormont D: Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science 1997, 275:402-404. A significant paper that casts doubt on the dogma that infectivity of prion diseases depends upon the transfer of PrP.
5. Holman RC, Khan AS, Kent J, Strine TW, Schonberger LB: Epidemiology of Creutzfeldt-Jakob disease in the United States, 1979-1990: analysis of national mortality data. Neuroepidemiology 1995, 14: 174-181.
6. Alpérovitch A: Epidemiology of Creutzfeldt-Jakob disease: past and present uncertainties. Eur J Neurology 1996, 3:500-506.
7. Scrimgeour EM, Chand PR, Kimbra K, Brown P: Creutzfeldt-Jakob disease in Oman: report of two cases. J Neurosci 1996, 142:148-150.
8. Masullo C, Brown PW, Macchi G: Creutzfeldt-Jakob disease in an Iranian: the first clinico-pathologically described case. Clin Neuropathol 1996, 15:26-29.
9. Mastrianni JA, Prusiner SB: The prevalence of heritable prion disease is underestimated by clinical assessment [Letter]. Neurology 1996, 46:313.
10. Jellinger KA, Budka H: The prevalence of Creutzfeldt-Jakob disease [Letter]. Neurodegeneration 1996, 5:111.
11. Hainfellner JA, Jellinger K, Diringer H, Guentchev M, Kleinert R, Pilz P, Maier H, Budka H: Creutzfeldt-Jakob disease in Austria. J Neurol Neurosurg Psychiatry 1996, 61:139-142.
12. Bruton CJ, Bruton RK, Gentleman SM, Roberts GW: Diagnosis and incidence of prion (Creutzfeldt-Jakob) disease: a retrospective archival survey with implications for future research. Neurodegeneration 1995, 4:357-368.
13. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hofman A, Smith PG: A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996, 347:921-925. This is the pioneering report detailing the 10 cases that had been described, stressing the unique clinical and pathological features and suggesting the possibility that BSE might be involved.
14. Korczyn AD: Bovine spongiform encephalopathy and Creutzfeldt-Jakob disease: a beefy problem? Singapore Med J 1996, 37:245-246.
15. Edney ATB: Spongiform encephalopathies: still many unanswered questions. J R Soc Med 1996, 89:424-426.
16. Cousens SN, Vynnycky E, Zeidler M, Will RG, Smith PG: Predicting the CJD epidemic in humans. Nature 1997, 385:197-198.
17. Chapman J, Ben-Israel J, Goldhammer Y, Korczyn AD: The risk of developing Creutzfeldt-Jakob disease in subjects with the PRNP gene codon 200 point mutation. Neurology 1994, 44:1683-1686.
18. Spudich S, Mastrianni JA, Wrensch M, Gabizon R, Meiner Z, Kahana I, Rosenmann H, Kahana E, Prusiner SB: Complete penetrance of Creutzfeldt-Jakob disease in Libyan Jews carrying the E200K mutation in the prion protein gene. Mol Med 1995, 6:607-613.
19. Salvatore M, Pocchiari M, Cardone F, Petraroli R, D'Alessandro M, Galvez S, Brown P, Macchi G, Fieschi C, Colosimo C: Codon 200 mutation in a new family of Chilean origin with Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 1996, 61:111-123.
20. Lys mutation: an analysis of 45 families. Eur J Epidemiol 1991, 7:477-486.
21. Wientjens DPWM, Davanipour Z, Hofman A, Kondo K, Matthews WB, Will RG, van Duijn CM: Risk factors for Creutzfeldt-Jakob disease: a reanalysis of case-control studies. Neurology 1996, 46:1287-1291.
22. Kothbauer-Margreiter I, Baumgartner RW, Bassetti C, Mathis J: Hemisensory deficit in a patient with Creutzfeldt-Jakob disease. Eur Neurol 1996, 36:108-109.
23. Vargas ME, Kupersmith MJ, Savino PJ, Petito F, Frohman LP, Warren FA: Homonymous field defect as the first manifestation of Creutzfeldt-Jakob disease. Am J Ophthalmol 1995, 119:497-504.
24. Chapman J, Brown P, Goldfarb LG, Arlazaroff A, Gajdusek DC, Korczyn AD: Clinical heterogeneity and unusual presentations of Creutzfeldt-Jakob disease in Jewish patients with PRNP codon 200 mutation. J Neurol Neurosurg Psychiatry 1993, 56: 1109-1112.
25. Chapman J, Arlazoroff A, Goldfarb LG, Cervenakova L, Neufeld MY, Werber E, Herbert M, Brown P, Gajdusek DC, Korczyn AD: Fatal insomnia in a case of familial Creutzfeldt-Jakob disease with the codon 200(Lys) mutation. Neurology 1996, 46:758-761.
26. Shabtai H, Nisipeanu P, Chapman J, Korczyn AD: Pruritus in Creutzfeldt-Jakob disease. Neurology 1996, 46:940-941.
27. Neufeld M, Josiphov J, Korczyn D: Demyelinating peripheral neuropathy in Creutzfeldt-Jakob disease. Muscle Nerve 1992, 15:1234-1239.
28. Antoine JC, Laplanche JL, Mosnier JF, Beaudry P, Chatelain J, Michel D: Demyelinatlng peripheral neuropathy with Creutzfeldt-Jakob disease and mutation at codon 200 of the prion protein gene. Neurology 1996, 46:1123-1126.
29. Ghetti B, Piccardo P, Spillantini MG, Ichimiya Y, Porro M, Perini F, Kitamoto T, Tateishi J, Seiler C, Frangione B et al.: Vascular variant of prion protein cerebral amyloidosis with τ-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. Neurobiology 1996, 93:744-748.
30. Shyu W-C, Lee C-C, Hsu Y-D, Lin J-pC, Lee J-T, Lee W-pH, Tsao W-L: Panencephalitic Creutzfeldt-Jakob disease: unusual presentation of magnetic resonance imaging and proton magnetic resonance spectroscopy. J Nucl Sci Technol 1996, 138:157-160.
31. Carola A, Pizzolato GP, Gailloud P, Macchi G, Fasel J, Le Floch J, Cardone F: A panencephalopathic type of Creutzfeldt-Jakob disease with selective lesions of the thalamic nuclei in 2 Swiss patients. Clin Neuropathol 1996, 15:125-134.
32. Chazot G, Broussole E, Lapras C, Blutter T, Aguzzi A, Kopp N: New variant of Creutzfeldt-Jakob disease in a 26-year-old French man [Letter]. Lancet 1996, 347:1181.
33. Deslys J-P, Lasmèzas CI, Streichenberger N, Hill A, Collinge J, Dlormont D, Kopp N: New variant Creutzfeldt-Jakob disease in France. Lancet 1997, 349:3-5.
34. Gambetti P: Fatal familial insomnia and familial Creutzfeldt-Jakob disease: a tale of two diseases with the same genetic mutation. Curr Topics Microbiol Immunol 1996, 207:19-25. This is an outstanding clear review of the clinical and pathological manifestations of FFI and the biological processes that underlie this disorder and CJD associated with the same mutation on codon 178.
35. Gallassi R, Morreale A, Montagna P, Cortelli P, Avoni P, Castellani R, Gambetti P, Lugaresi E: Fatal familial insomnia: behavioral and cognitive features. Neurology 1996, 46:935-939.
36. Mastrianni JA, Curtis MT, Oberholtzer JC, Da Costa MM, DeArmond S, Prusiner SB, Garbern JY: Prion disease (PrP-A117V) presenting with ataxia instead of dementia. Neurology 1995, 45:2042-2050.
37. Furukawa H, Kitamoto T, Tanaka Y, Tateishi J: New variant prion protein in a Japanese family with Gerstmann-Sträussler syndrome. Mol Brain Res 30:385-388.
38. Petraroli R, Pocchiari M: Codon 219 polymorphism of PRNP in healthy Caucasians and Creutzfeldt-Jakob disease patients. Am J Hum Genet 1996, 58:888-889.
39. Campbell TA, Palmer MS, Will RG, Gibb WRG, Luthert PJ, Collinge J: A prion disease with a novel 96-base pair insertional mutation in the prion protein gene. Neurology 1996, 46:761-766.
40. Salvatore M, Seeber AC, Nacmias B, Petraroli R, D'Alessandro M, Sorbi S, Pocchian M: Apolipoprotein E in sporadic and familial Creutzfeldt-Jakob disease. Neurosci Lett 1995, 199:95-98.
41. Zerr I, Helmhold M, Poser S, Armstrong VW, Weber T: Apolipoprotein E phenotype frequency and cerebrospinal fluid concentration are not associated with Creutzfeldt-Jakob disease. Arch Neurol 1996, 53:1233-1238.
42. Goldfarb LG, Chapman J, Brown P, Cervenàkovà L, Gajdusek DC, Korczyn AD: Apolipoprotein E genotype in human spongiform encephalopathies [Abstract]. Neurology 1996, 46:187.
43. Pickering-Brown SM, Mann DMA, Owen F, Ironside JW, de Silva R, Roberts DA, Balderson DJ, Cooper PN: Allelic variations in apolipoprotein E and prion protein genotype related to plaque formation and age of onset in sporadic Creutzfeldt-Jakob disease. Neurosci Lett 1995, 187:127-129.
44. Budka H, Aguzzi A, Brown P, Brucher J-M, Bugiani O, Gullotta F, Haltia M, Hauw J-J, Ironside JW, Jellinger K et al.: Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol 1995, 5:459-466.
45. Castellani R, Parchi P, Stahl J, Capellari S, Cohen M, Gambetti P: Early pathologic and biochemical changes in Creutzfeldt-Jakob disease: study of brain biopsies. Neurology 1996, 46:1690-1693.
46. Sc after ingestion of food contaminated by BSE. Data on sporadic cases with CJD, unassociated with BSE, are awaited.
47. Schreuder BEC, van Keulen LJM, Vromans MEW, Langeveld JPM, Smits MA: Preclinical test for prion diseases. Nature 1996, 381:563.
48. Garcia Santos JM, López Corbalán JA, Martinez-Lage JF, Sicilia Guillén J: CT and MRI in iatrogenic and sporadic Creutzfeldt-Jakob disease: as far as imaging perceives. Neuroradiology 1996, 38:226-231.
49. Ishida S, Sugino M, Koizumi N, Shinoda K, Ohsawa N, Ohta T, Kitamoto T, Tateishi J: Serial MRI in early Creutzfeldt-Jakob disease with a point mutation of prion protein at codon 180. Neuroradiology 1995, 37:531-534.
50. Finkenstaedt M, Szudra A, Zerr I, Poser S, Hise JH, Stoebner JM, Weber T: MR imaging of Creutzfeldt-Jakob disease. Radiology 1996, 199:793-798.
51. Featherstone T: Magnetic resonance imaging may have a role in diagnosing Creutzfeldt-Jakob disease. Br Med J 1996, 312:180-181.
52. Yoon SS, Chan S, Chin S, Lee K, Goodman RR: MRI of Creutzfeldt-Jakob disease: asymmetric high signal intensity of the basal ganglia. Neurology 1995, 45:1932-1933.
53. Liou H-H, Chiu H-C, Liu H-M: Abnormal enhancement of the left putamen on brain MRI in a case of proven Creutzfeldt-Jakob disease. Eur Neurol 1996, 36:107-108.
54. Ogawa T, Inugami A, Fujita H, Hatazawa J, Shimosegawa E, Kanno I, Okudera T, Uemura K, Nagata K: Serial positron emission tomography with fludeoxyglucose F 18 in Creutzfeldt-Jakob disease. Am J Neuroradiol 1995, 16(suppl):978-981.
55. Matochik JA, Molchan SE, Zametkin AJ, Warden DL, Sunderland T, Cohen RM: Regional cerebral glucose metabolism in autopsy-confirmed Creutzfeldt-Jakob disease. Acta Neurol Scand 1995, 91:153-157.
56. Cohen D, Krausz Y, Lossos A, Ben-David E, Allan H: Brain SPECT imaging with Tc-99m HMPAO in Creutzfeldt-Jakob disease. Clin Nucl Med 1989, 14:808-810.
57. Kao C-H, Wang S-J, Liao S-Q, Yeh S-H: Tc-99m HMPAO brain SPECT findings in Creutzfeldt-Jakob disease. Clin Nucl Med 1993, 18:234-236.
58. Aharon-Peretz J, Peretz A, Hemli JA, Honigman S, Israel O: SPECT diagnosis of Creutzfeldt-Jakob disease. J Nucl Med 1995, 36:616-617.
59. Steinhoff BJ, Räcker S, Herrendorf G, Poser S, Grosche S, Zerr I, Kretzschmar H, Weber T: Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease. Arch Neurol 1996, 53:162-166.
60. Pollak L, Klein C, Giladi R, Kertesz J, Arlazoroff A: Progressive deterioration of brainstem auditory evoked potentials in Creutzfeldt-Jakob disease: clinical and electroencephalographic correlation. Clin Electroencephalogr 1996, 27:95-99.
61. Harrington MG, Merril CR, Asher DM, Gajdusek DC: Abnormal proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. N Engl J Med 1986, 315:279-283.
62. Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG: The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 1996, 335:924-930. It is remarkable how long it took for the original data of Harrington et al. [61] to be confirmed, and had it not been for BSE this may never have happened. How this protein gets into the cerebrospinal fluid is unknown. It may reflect cerebral tissue damage, because positive results were found in stroke patients and some with herpes encephalitis. If so, the changes may only develop late in CJD and would not be helpful for early diagnosis.
63. Zerr I, Bodemer M, Räcker, Grosche S, Poser S, Kretzschmar HA. Weber T: Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease. Lancet 1995, 345:1609-1610.
64. Holmes SJ, Ironside JW, Shalet SM: Neurosurgery in a patient with Creutzfeldt-Jakob disease after pituitary derived growth hormone therapy in childhood. J Neurol Neurosurg Psychiatry 1996, 60:333-335.
65. Collins SJ, Masters CL: Transmissibility of Creutzfeldt-Jakob disease and related disorders. Sci Prog 1995, 78:217-227.
66. van Asten JAAM, Geertsma RE, Dorpema J-W: Prions and hospital infections. Lancet 1996, 347:966-967.
67. Hainfellner JA, Jellinger K, Budka H: Testing for prion protein does not confirm previously reported conjugal CJD. Lancet 1996, 347:616-617.
68. Budka H, Aguzzi A, Brown P, Brucher J-M, Bugiani O, Collinge J, Diringer H, Gullotta F, Haltia M, Hauw J-J et al.: Tissue handling in suspected Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol 1995, 5:319-322. Several neurologists are reluctant to perform autopsy on suspected CJD patients. This concensus report is therefore important in setting guidelines and alleviating fears.
69. Brown P: Can CJD be transmitted by transfusion? Curr Opin Haematol 1995, 2:472-477.
70. Operskalski EA, Mosley JW: Pooled plasma derivatives and Creutzfeldt-Jakob disease [Letter]. Lancet 1995, 346:1224.
71. Dealler S: A matter for debate: the risk of bovine spongiform encephalopathy to humans posed by blood transfusion in UK. Transfusion Med 1996, 6:217-222.
72. Siegel-Itzkovich J: Blood tests urged for CJD carriers. Br Med J 1997, 314:170.
73. Wickham EA: Potential transmission of BSE via medicinal products. Br Med J 1996, 312:989-989.
74. Ridley RM, Baker HF: The myth of maternal transmission of spongilorm encephatopatrty. Br Med J 1995, 311:1071-1074.
75. Gabizon R, Telling G, Meiner Z, Halimi M, Kahana I, Prusiner SB: insoluble wild-type and protease-resistant mutant prion protein in brains of patients with inherited prion disease. Nature Med 1996, 2:59-64.
76. Tagliavini F, Prelli F, Porro M: Amyloid fibrils in Gerstmann-Sträussier-Scheinker disease (Indiana and Swedish kindreds) express only PrP peptides encoded by the mutant allele. Cell 1994, 79:695-703.
77. Lehmann S, Harris DA: Two mutant prion proteins expressed in cultured cells acquire biochemical properties reminiscent of the scrapie isoform. Proc Nat Acad Sci U S A 1996, 93:5610-5614.
78. Sc exist in humans.
79. Sc are unknown. It is assumed that another protein, dubbed protein X, is involved in this interaction. Formulation of the molecular interactions could assist in the understanding of the species barrier, and may even direct towards therapeutic interventions.
80. Sc strain that is apparently identical to that found in BSE.
81. Parchi P, Castellani R, Capellari S, Bernardino G, Young K, Chen SG, Farlow M, Dickson DW, Sima AAF, Trojanowski JQ et al.: Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 1996, 39:767-778.
82. Lasmézas CI, Deslys J-P, Demaimay R, Adjou KT, Lamoury F, Dormont D, Robain O, Ironside J, Hauw J-J: BSE transmission to macaques. Nature 1996, 381:743-744.
83. Gabizon R, Taraboulos A: Of mice and (mad) cows: transgenic mice help understand prions. Trends Genet 1997 (in press).
84. Krakauer DC, Pagel M, Southwood TRE, Zanotto PM de A: Phylogenesis of prion protein. Nature 1996, 380:675.
85. Baker HF, Ridley RM (Eds): Prion diseases. Totowa, NJ: Humana Press; 1996.
86. Court L, Dodet B (Eds): Transmissible subacute spongiform encephalopathies: prion diseases. Paris: Elsevier; 1996.